Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tradr 2X Short TSLA Daily ETF
TSLQ
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
RXRX Recursion Pharmaceuticals
- 5.720
- -0.120-2.05%
Close Apr 29 16:00 ET
- 5.400
- -0.320-5.59%
Pre 09:00 ET
2.30BMarket Cap-3.38P/E (TTM)
5.940High5.680Low10.68MVolume5.870Open5.840Pre Close61.82MTurnover2.79%Turnover RatioLossP/E (Static)401.99MShares12.36052wk High2.22P/B2.19BFloat Cap3.79052wk Low--Dividend TTM382.61MShs Float42.810Historical High--Div YieldTTM4.45%Amplitude3.790Historical Low5.788Avg Price1Lot Size
About Recursion Pharmaceuticals Company
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.
Company Profile
SymbolRXRX
Company NameRecursion Pharmaceuticals
Listing DateApr 16, 2021
Issue Price18.00
Founded2013
CEODr. Christopher Gibson, PhD
MarketNASDAQ
Employees800
Fiscal Year Ends12-31
Address41 South Rio Grande Street
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84101
Phone1-385-269-0203
Websitehttp://www.recursion.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher Gibson, PhD
- Chief Executive Officer, Director and President
- 8.50M
- Ben R. Taylor
- Chief Financial Officer, Principal Accounting Officer and President, Recursion UK
- 8.17M
- Dr. Najat Khan, PhD
- Director, Chief Research and Development Officer and Chief Commercial Officer
- 9.19M
- Dr. Robert M. Hershberg, M.D.,PhD
- Chairman of the Board
- 316.48K
- Elaine D. Sun
- Director
- --
- Dr. Namandje N. Bumpus, PhD
- Director
- --
- Dr. Franziska Michor, PhD
- Director
- 753.11K
- Zavain Dar, PhD
- Independent Director
- 304.23K
- Zachary Bogue, J.D.
- Independent Director
- 21.25K
- Dean Y. Li, M.D.,PhD
- Independent Director
- 296.73K
- Dr. Blake Borgeson, PhD
- Independent Director
- 294.98K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call